Publiserte artikler

​​Medikamentell behandling og oppfølging

B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment

Benefit from B-Lymphocyte Depletion Using the Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome. A Double-Blind and Placebo-Controlled Study

Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series

Studie viser ikke effekt av behandling med rituximab hos pasienter med ME/CFS

Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study

B-lymphocyte Depletion in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. A Randomized, Double-Blind, Placebo-Controlled Tri

Artikler fra laboratoriearbeid og bruk av biobankmateriale

Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy / chronic fatigue syndrome

Antibodies to ß adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome

Immunosignature Analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Rituximab serum concentrations and anti-rituximab antibodies during B-cell depletion therapy for ME/CFS

JCI Insight - A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome​

Monitoreringsstudie og fysiske tester

Endothelial dysfunction in ME/CFS patients | PLOS One

Reduced endothelial function in ME/CFS – results from cyclophosphamide study

Activity monitoring and patient-reported outcome measures in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients

Genetikk:

Human Leukocyte Antigen alleles associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). - Abstract - Europe PMC

Fine mapping of the major histocompatibility complex (MHC) in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) suggests involvement of both HLA class I and class II loci - PubMed

Genetic association study in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) identifies several potential risk loci - PubMed

No replication of previously reported association with genetic variants in the T cell receptor alpha (TRA) locus for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) | Translational Psychiatry
​